Composite fiber membrane, preparation method and application of composite fiber membrane in diabetic wound dressing
By forming a coordinated adsorption structure of Cu2+ with spermidine and ergothionine on the composite fiber membrane, blood response release is achieved, the problem of difficulty in healing in diabetic wounds is solved, the wound healing rate and angiogenesis are significantly improved, and oxidation is controlled Stress and inflammation.
Patent Information
- Application Number
- CN202411128321.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-16
AI Technical Summary
Diabetes leads to vascular damage and chronic inflammation, which makes it difficult to heal wounds. The prior art is difficult to effectively promote healthy vascular formation and wound healing.
Using the preparation method of composite fiber membranes, nanofiber membranes are prepared by electrospinning, and spermidine and ergothioneine are reacted on them to form a coordination adsorption structure. Cu2+ is used to combine with spermidine and ergothioneine to achieve blood response. Release, promotes healthy vascularization and wound healing.
Release of spermidine and ergothionine through blood responses promotes healthy vascular formation, controls oxidative stress and anti-inflammatory, and significantly improves the healing rate and angiogenesis of diabetic wounds.
Smart Images

Figure CN119020996A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical engineering, and in particular relates to a composite fiber membrane, a preparation method and application of the composite fiber membrane in diabetic wound dressings. Background Art
[0002] Diabetes can cause vascular atherosclerosis and thickening of the microvascular basement membrane, glycogen deposition, and fatty and hyaline degeneration. The endothelial cells in the blood vessels are the natural barrier between the blood and the blood vessel wall. High blood sugar can cause damage to the vascular endothelial structure and destroy the integrity of the blood vessel wall. After the vascular endothelium is damaged, the subendothelial collagen is exposed. In order to "stop bleeding", platelets will be activated, agglutinate and form thrombi at the damaged site, and attract fat to deposit under the endothelium, causing local blood vessels to narrow. The more glucose in the blood, the more concentrated the blood, the slower the blood flow, the higher the blood viscosity, and the more likely it is to present a hypercoagulable state. At the same time, vascular endothelial cells are damaged, and cholesterol is more likely to deposit under the endothelium to form atherosclerotic plaques, which promote the occurrence and development of cardiovascular events. The increase in lipids, viscous blood, and narrow blood vessels will increase the deposition of lipids on the endothelium. If not properly controlled, it will "block" the blood vessels and develop into plaques, eventually leading to atherosclerosis. The blood vessels where the plaques are located will have decreased elasticity and increased fragility, resulting in an increased risk of vascular rupture and hemorrhagic diseases.
[0003] Due to the existence of vascular disease mechanisms, the new blood vessels at the wound healing site of diabetic wounds are often poorly generated at the beginning and have basic defects, causing inflammatory factors to penetrate outside the blood vessels. Long-term chronic inflammation can seriously cause the wound to fail to heal. Summary of the invention
[0004] In view of this, the object of the present invention is to provide a diabetic wound dressing and a preparation method thereof, wherein the dressing releases spermidine and ergothioneine through blood response, accelerates and improves the formation of healthy blood vessels, and promotes diabetic wound healing while controlling oxidative stress and anti-inflammation.
[0005] In order to solve the above technical problems, the present invention provides the following technical solutions
[0006] A first aspect of the present invention provides a method for preparing a composite fiber membrane, comprising the following steps:
[0007] S1. Preparation of nanofiber membrane: polyurethane and polyvinylpyrrolidone (PVP) are dissolved in a mixed solvent of N,N-dimethylformamide (DMF) and tetrahydrofuran (THF), copper salt and meso-tetrakis(4-carboxyphenyl)porphine are added, stirred thoroughly and ultrasonicated to make the dispersion uniform, and the mixture is oscillated at 80-90°C for 12-20h to obtain a spinning solution, and the spinning solution is electrospun to obtain a nanofiber membrane;
[0008] S2. Treatment of the reaction solution: immerse the nanofiber membrane obtained in step S1 in a 50-80 w / v% ethanol solution containing spermidine and ergothioneine, stir gently, slowly drop 10-15 w / v% sodium hydroxide solution until the solution pH value is 9.5-10.0, and then continue for 24-48 hours, take out the membrane, drain and wash to obtain a composite fiber membrane.
[0009] Preferably, in step S1, in the mixed solvent of N,N-dimethylformamide and tetrahydrofuran, the volume ratio of N,N-dimethylformamide to tetrahydrofuran is 1:1.
[0010] Preferably, in step S1, the polyurethane is Carbothane aromatic thermoplastic polyurethane, the model is one of AC-4075A-B20, AC-4085A-B20 and AC-4095A-B20, and the concentration used is 9-12 w / v%.
[0011] Preferably, in step S1, the PVP is one of PVP-K25, PVP-K30 and PVP-K40, and the concentration used is 3-5 w / v%.
[0012] Preferably, in step S1, the copper salt is one of copper nitrate, copper chloride and copper sulfate, and the added amount is 0.15-0.20 w / v%.
[0013] Preferably, in step S1, in the mixed solution, the concentration of polyurethane is 9-12w / v%, the concentration of polyvinyl pyrrolidone is 3-5w / v%, the concentration of copper salt is 0.15-0.20w / v%, and the concentration of meso-tetrakis(4-carboxyphenyl)porphine is 0.62-0.83w / v%.
[0014] Preferably, in step S1, the electrospinning conditions are: voltage 16-20 kV, ambient humidity 20%-30% RH, ambient temperature 60-80°C, spinning distance 15-20 cm, spinning solution flow rate 0.7-1.5 ml / h.
[0015] Preferably, in step S2, in the ethanol solution containing spermidine and thioneine, the concentration of spermidine is 0.14-0.28w / v%, and the concentration of thioneine is 1.80-2.40w / v%.
[0016] Preferably, in step S2, the bath ratio of the nanofiber membrane is 40-60:1.
[0017] Preferably, in step S2, the pH value is adjusted to 9.5-10.0 by slowly dripping a sodium hydroxide solution until the pH value is 9.5-10.0; the concentration of the sodium hydroxide solution is 10-15 w / v%, and the dripping rate is 0.8-1.2 v / v% / min.
[0018] Preferably, in step S2, the washing specifically comprises: rinsing the composite fiber membrane with physiological saline for 3-5 times.
[0019] The second aspect of the present invention also provides a composite fiber membrane prepared by the above preparation method.
[0020] The third aspect of the present invention also provides the use of the above-mentioned composite fiber membrane in diabetic wound dressings.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] 1) The present invention constructs a polyurethane fiber with meso-tetrakis(4-carboxyphenyl)porphine and Cu 2+ Based on the metal organic framework structure, Cu 2+ It has multiple coordination numbers, and spermidine and ergothioneine are then bound to the main Cu through the lone pair electrons on the amino, thiol, and carbon-sulfur groups. 2+ This can form coordination adsorption. 2+ If the system contains Fe 2+ , Fe 2+ Can be used with Cu 2+ Competitive coordination binds spermidine and ergothioneine, allowing spermidine and ergothioneine to be released.
[0023] 2) Ergothioneine has antioxidant properties, which can prevent spermidine from being quickly consumed by polyamine oxidase at the wound site, thereby increasing the bioavailability of spermidine. Spermidine can promote protein synthesis or prevent protein degradation. Spermidine also has neuroprotective effects; stimulates muscle protein synthesis, promotes muscle growth and repair; improves vascular elasticity, lowers blood pressure and cholesterol levels; and has a regulatory effect on the immune system, which can enhance the body's immunity and improve the ability to resist disease. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a scanning electron microscope photo of the diabetic wound dressing prepared in Example 1;
[0025] Figure 2 This is the curve of the healing rate changing with time in the diabetic wound healing experiment;
[0026] Figure 3 This is the relative expression result of VEGF in callus tissue on the 4th day of the diabetic wound healing experiment. DETAILED DESCRIPTION
[0027] In order to further understand the present invention, preferred embodiments of the present invention are described below in conjunction with examples, but it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention, rather than limiting the claims of the present invention.
[0028] Example 1
[0029] A method for preparing a composite fiber membrane (diabetic wound dressing) comprises the following steps:
[0030] 1. Preparation of nanofiber membrane: Carbothane aromatic thermoplastic polyurethane AC-4085A-B20 and PVP-K30 were dissolved in an equal volume mixed solvent of DMF and THF, the polyurethane concentration was 10w / v%, the PVP concentration was 4w / v%, and then 0.18w / v% copper nitrate and 0.78w / v% of tetrakis(4-carboxyphenyl)porphine were added, fully stirred and ultrasonicated to make the dispersion uniform, placed at 85°C for 18h of oscillation reaction, and then the solution was electrospun under the conditions of voltage 18kV, ambient humidity 25%RH, ambient temperature 70°C, spinning distance 17cm, spinning solution flow rate 1.0ml / h to obtain nanofiber membrane;
[0031] 2. Reaction solution treatment: The nanofiber membrane prepared in step 1 was immersed in a 65w / v% ethanol solution containing 0.20w / v% spermidine and 2.00w / v% ergothioneine at a bath ratio of 50:1, and gently stirred. A 12w / v% sodium hydroxide solution was added dropwise at a rate of 1v / v% / min until the pH value of the solution was 9.8. The reaction mixture was then continued for 36 hours, the membrane was taken out, and the composite fiber membrane was obtained by draining.
[0032] 3. Washing: The composite fiber membrane prepared in step 2 was rinsed with physiological saline for 4 times to obtain a diabetic wound dressing ( Figure 1 ).
[0033] Example 2
[0034] A method for preparing a composite fiber membrane (diabetic wound dressing) comprises the following steps:
[0035] 1. Preparation of nanofiber membrane: Carbothane aromatic thermoplastic polyurethane AC-4075A-B20 and PVP-K25 were dissolved in an equal volume mixed solvent of DMF and THF, the polyurethane concentration was 9w / v%, the PVP concentration was 3w / v%, and then 0.15w / v% copper chloride and 0.62w / v% of tetrakis(4-carboxyphenyl)porphine were added, fully stirred and ultrasonicated to make the dispersion uniform, placed at 80°C for oscillation reaction for 20h, and then the solution was electrospun under the conditions of voltage 16kV, ambient humidity 20%RH, ambient temperature 60°C, spinning distance 15cm, spinning solution flow rate 0.7ml / h to obtain nanofiber membrane;
[0036] 2. Reaction solution treatment: The nanofiber membrane prepared in step 1 was immersed in a 50 w / v% ethanol solution containing 0.14 w / v% spermidine and 1.80 w / v% ergothioneine at a bath ratio of 40:1, and gently stirred. A 10 w / v% sodium hydroxide solution was added dropwise at a rate of 0.8 v / v% / min until the pH value of the solution was 9.5. The reaction mixture was then continued for 24 h, the membrane was taken out, and the composite fiber membrane was obtained by draining.
[0037] 3. Washing: Rinse the composite fiber membrane obtained in step 2 with physiological saline for 3 times to obtain a diabetic wound dressing.
[0038] Example 3
[0039] A method for preparing a composite fiber membrane (diabetic wound dressing) comprises the following steps:
[0040] 1. Preparation of nanofiber membrane: Carbothane aromatic thermoplastic polyurethane AC-4095A-B20 and PVP-K40 were dissolved in an equal volume mixed solvent of DMF and THF, the polyurethane concentration was 12w / v%, the PVP concentration was 5w / v%, and then 0.20w / v% copper sulfate and 0.83w / v% of tetrakis(4-carboxyphenyl)porphine were added, fully stirred and ultrasonicated to make the dispersion uniform, placed at 90°C for 12h of oscillation reaction, and then the solution was electrospun under the conditions of voltage 20kV, ambient humidity 30%RH, ambient temperature 80°C, spinning distance 20cm, spinning solution flow rate 1.5ml / h to obtain nanofiber membrane;
[0041] 2. Reaction solution treatment: The nanofiber membrane prepared in step 1 was immersed in an 80 w / v% ethanol solution containing 0.28 w / v% spermidine and 2.40 w / v% ergothioneine at a bath ratio of 60:1, and gently stirred. A 15 w / v% sodium hydroxide solution was added dropwise at a rate of 1.2 v / v% / min until the pH value of the solution was 10.0. The reaction mixture was then continued for 48 hours, the membrane was taken out, and the composite fiber membrane was obtained by draining.
[0042] 3. Washing: Rinse the composite fiber membrane obtained in step 2 with physiological saline for 5 times to obtain a diabetic wound dressing.
[0043] Comparative Example 1 (without Cu-MOFs)
[0044] A method for preparing a dressing comprises the following steps:
[0045] 1. Preparation of nanofiber membrane: Carbothane aromatic thermoplastic polyurethane AC-4085A-B20 and PVP-K30 were dissolved in an equal volume mixed solvent of DMF and THF, the polyurethane concentration was 10w / v%, the PVP concentration was 4w / v%, and the mixture was fully stirred and ultrasonically dispersed uniformly, and placed at 85°C for oscillation reaction for 18h, and then the solution was electrospun under the conditions of voltage 18kV, ambient humidity 25%RH, ambient temperature 70°C, spinning distance 17cm, and spinning solution flow rate 1.0ml / h to obtain nanofiber membrane;
[0046] 2. Reaction solution treatment: The nanofiber membrane prepared in step 1 was immersed in a 65w / v% ethanol solution containing 0.20w / v% spermidine and 2.00w / v% ergothioneine at a bath ratio of 50:1, and gently stirred. A 12w / v% sodium hydroxide solution was added dropwise at a rate of 1v / v% / min until the pH value of the solution was 9.8. The reaction mixture was then continued for 36 hours, the membrane was taken out, and the composite fiber membrane was obtained by draining.
[0047] 3. Washing: Rinse the composite fiber membrane obtained in step 2 with physiological saline for 4 times to obtain a dressing.
[0048] Comparative Example 2 (without ergothioneine)
[0049] A method for preparing a dressing comprises the following steps:
[0050] 1. Preparation of nanofiber membrane: Carbothane aromatic thermoplastic polyurethane AC-4085A-B20 and PVP-K30 were dissolved in an equal volume mixed solvent of DMF and THF, the polyurethane concentration was 10w / v%, the PVP concentration was 4w / v%, and then 0.18w / v% copper nitrate and 0.78w / v% of tetrakis(4-carboxyphenyl)porphine were added, fully stirred and ultrasonicated to make the dispersion uniform, placed at 85°C for 18h of oscillation reaction, and then the solution was electrospun under the conditions of voltage 18kV, ambient humidity 25%RH, ambient temperature 70°C, spinning distance 17cm, spinning solution flow rate 1.0ml / h to obtain nanofiber membrane;
[0051] 2. Treatment of reaction solution: Immerse the nanofiber membrane prepared in step 1 in a 65w / v% ethanol solution containing 0.20w / v% spermidine with a bath ratio of 50:1. Stir gently and add 12w / v% sodium hydroxide solution dropwise at a rate of 1v / v% / min until the pH value of the solution is 9.8. Continue for 36 hours, take out the membrane, and drain to obtain a composite fiber membrane.
[0052] 3. Washing: Rinse the composite fiber membrane obtained in step 2 with physiological saline for 4 times to obtain a dressing.
[0053] Diabetes wound healing experiment
[0054] 8-week-old male SD rats were selected, fed with a high-fat and high-sugar diet for 4 weeks, and induced to become type 2 diabetes by a one-time intraperitoneal injection of streptozotocin at 35 mg / kg. They were randomly divided into 6 groups according to body weight using a random number table method, with 5 rats in each group. After anesthesia, hair was removed from both sides of the back, and after disinfection with iodine, a circular wound with a diameter of about 1 cm was excised with a puncher, and the dressings prepared in Examples 1-3 and Comparative Examples 1-2 and commercially available dressings (Warm Medical alginate dressings and Coloplast Kanghuier 3903 wound hydrogel dressings) were used, respectively, and then wrapped and fixed with medical gauze, and the wound area was recorded to calculate the healing rate (the percentage of the wound area to the original wound area). The results are shown in Table 1. Figure 2 Animal models were established in the same manner. The animals were treated with the dressings prepared in Examples 1-3 and Comparative Examples 1-2 and commercially available dressings (Warm Medical alginate dressings and Coloplast Convergence 3903 wound hydrogel dressings) for 4 days before being killed. The wound tissues were taken for determination of VEGF expression by Western blot (with β-actin as an internal reference). The statistical results are shown in Figure 3 .
[0055] Depend on Figure 2-Figure 3 It can be known that the dressing prepared by the embodiment of the present invention has the effect of improving VEGF expression. VEGF, vascular endothelial growth factor, also known as vascular permeability factor, is a highly specific vascular endothelial cell growth factor that can reflect angiogenesis. The diabetic wound angiogenesis of the dressing processed by the embodiment is good, and abundant healthy blood vessels are conducive to the rapid healing of wounds. However, there is no Cu-MOFs formation in the dressing of comparative example 1, and the main structure centered on metal ions is lacking in the fiber, and it is impossible to effectively coordinate and adsorb spermidine and thioneine, so the spermidine and thioneine contained in the dressing are less, and there is no blood responsiveness, and it is impossible to play the role of promoting angiogenesis and wound healing. There is no thioneine in the dressing of comparative example 2, when spermidine enters the tissue fluid, it will be metabolized by polyamine oxidase faster, and it is impossible to maintain effective drug concentration, then the formation of blood vessels and health status will be affected by high blood sugar, which is unfavorable for wound healing. In addition, two commercially available wound dressings do not take measures for the new growth of healthy blood vessels, so the wound healing effect is also not good.
[0056] The present invention provides a composite fiber membrane, a preparation method and a method for its application in diabetic wound dressings. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the protection scope of the present invention. All components not specified in this embodiment can be implemented by existing technologies.
Claims
1. A method for preparing a composite fiber membrane, It is characterized in that The steps include: S1. Preparation of nanofiber membrane: polyurethane and polyvinyl pyrrolidone are dissolved in a mixed solvent of N,N-dimethylformamide and tetrahydrofuran, copper salt and meso-tetrakis(4-carboxyphenyl)porphine are added, and the mixture is stirred and dispersed uniformly by ultrasound to obtain a mixed solution, the mixed solution is oscillated at 80-90° C. for 12-20 h to obtain a spinning solution, and the spinning solution is electrospun to obtain a nanofiber membrane; S2. Treatment of the reaction solution: immerse the nanofiber membrane in an ethanol solution containing spermidine and ergothioneine, adjust the pH value to 9.5-10.0, place it for 24-48 hours, take it out, drain it, wash it, and obtain a composite fiber membrane.
2. The preparation method according to claim 1, It is characterized in that In step S1, in the mixed solvent of N,N-dimethylformamide and tetrahydrofuran, the volume ratio of N,N-dimethylformamide to tetrahydrofuran is 1:
1.
3. The preparation method according to claim 1, It is characterized in that In step S1, the copper salt is one of copper nitrate, copper chloride and copper sulfate.
4. The preparation method according to claim 1, It is characterized in that In step S1, in the mixed solution, the concentration of polyurethane is 9-12w / v%, the concentration of polyvinyl pyrrolidone is 3-5w / v%, the concentration of copper salt is 0.15-0.20w / v%, and the concentration of meso-tetrakis(4-carboxyphenyl)porphine is 0.62-0.83w / v%.
5. The preparation method according to claim 1, It is characterized in that In step S1, the electrospinning conditions are: voltage 16-20 kV, ambient humidity 20%-30% RH, ambient temperature 60-80°C, spinning distance 15-20 cm, spinning solution flow rate 0.7-1.5 ml / h.
6. The preparation method according to claim 1, It is characterized in that In step S2, in the ethanol solution containing spermidine and thioneine, the concentration of spermidine is 0.14-0.28w / v%, and the concentration of thioneine is 1.80-2.40w / v%.
7. The preparation method according to claim 1, It is characterized in that In step S2, the bath ratio of the nanofiber membrane is 40-60:
1.
8. The preparation method according to claim 1, It is characterized in that In step S2, the pH value is adjusted to 9.5-10.0 by slowly dripping a sodium hydroxide solution until the pH value is 9.5-10.0; the concentration of the sodium hydroxide solution is 10-15 w / v%, and the dripping rate is 0.8-1.2 v / v% / min.
9. A composite fiber membrane prepared according to the preparation method according to any one of claims 1 to 8.
10. Use of the composite fiber membrane according to claim 9 in diabetic wound dressings.
Citation Information
Patent Citations
Wound dressing and preparation method thereof
CN116139322A
Composite nano antibacterial fiber membrane, preparation method and application thereof
CN117661193A
Application of spermidine, expression activity improving agent, ergothioneine and spermidine composition and application of ergothioneine and spermidine composition
CN118001264A
Organic polymer nano-composite fiber shrink film, preparation method thereof and application of shrink film in preparation of wound dressing
CN118147820A
Composite Particles Having An Antioxidant-Based Protective System, And Topical Compositions Comprising The Same
US20100040696A1
